The Diocese of Rockville Centre warned their three high schools on Long Island that students or fans kneeling or protesting during the national anthem before games or other school events could face? “serious disciplinary action.” ?“This is a reminder that all student-athletes and spectators are expected to stand during the playing of the National Anthem...
NYS Entity Status
NYS Filing Date
FEBRUARY 28, 2014
NYS DOS ID#
NYS Entity Type
DOMESTIC PROFESSIONAL SERVICE LIMITED LIABILITY COMPANY
2014 - NY PHYSICAL THERAPY WELLNESS, ROCKVILLE CENTRE, PLLC
Around the Web
- High schoolers warned not to protest national anthem
By Mark Moore - Thursday Sep 28, 2017
- Tom Colicchio Changes His Restaurant’s Racially Tinged Name
By KIM SEVERSON - Wednesday Aug 23, 2017
The chef is renaming Fowler & Wells, after learning about the name’s connection with the debunked theories of phrenology.
- How this woman escaped gulags of North Korea to become US college student
By Fox News - Thursday Oct 19, 2017
When Grace Jo walks along the leafy paths of Montgomery College in Rockville, Maryland, she is indistinguishable from any other American college student. But the 26-year-old’s astounding journey took her from the gulags of North Korea’s brutal dictatorship – and the very edge of starving to death – to a new, unimaginable life in the...
- How can I gain access to my own money?
By John Crudele - Sunday Oct 22, 2017
Dear John: Can you help me? I have had a $39,000 annuity with TIAA-CREF for many years. Now I am in financial distress. I am an 87-year-old retired schoolteacher from Rockville Center. I’ve been told I can retrieve some of this money only for legal bills or funeral expenses. What do you think? M.G. Dear...
- Stealthy NY Startup Rocket Pharma Merges With Inotek, Heads to Nasdaq
By Ben Fidler - Tuesday Sep 12, 2017
Rocket Pharmaceuticals, a stealthy gene therapy startup in New York City, has made its first splash. Through a merger with struggling Inotek Pharmaceuticals (NASDAQ: ITEK), Rocket, a company developing treatments for a variety of rare blood diseases, has taken itself public. Rocket shareholders are expected to own 81 percent of the combined company, with Inotek […]